LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Fundamental Analysis

BIT:1CYTH • US5502411037

7.345 EUR
-1.79 (-19.61%)
Last: Jan 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to 1CYTH. 1CYTH was compared to 33 industry peers in the Diversified Telecommunication Services industry. The financial health of 1CYTH is average, but there are quite some concerns on its profitability. 1CYTH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • 1CYTH had negative earnings in the past year.
  • 1CYTH had a positive operating cash flow in the past year.
  • 1CYTH had negative earnings in 4 of the past 5 years.
  • Each year in the past 5 years 1CYTH had a positive operating cash flow.
1CYTH.MI Yearly Net Income VS EBIT VS OCF VS FCF1CYTH.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

  • 1CYTH has a Return On Assets of -4.82%. This is amonst the worse of the industry: 1CYTH underperforms 83.33% of its industry peers.
  • 1CYTH's Return On Invested Capital of 0.42% is on the low side compared to the rest of the industry. 1CYTH is outperformed by 83.33% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1CYTH is significantly below the industry average of 8.59%.
Industry RankSector Rank
ROA -4.82%
ROE N/A
ROIC 0.42%
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
1CYTH.MI Yearly ROA, ROE, ROIC1CYTH.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • 1CYTH's Operating Margin of 1.34% is on the low side compared to the rest of the industry. 1CYTH is outperformed by 80.56% of its industry peers.
  • 1CYTH's Operating Margin has declined in the last couple of years.
  • 1CYTH has a Gross Margin of 47.07%. This is in the lower half of the industry: 1CYTH underperforms 61.11% of its industry peers.
  • In the last couple of years the Gross Margin of 1CYTH has declined.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 47.07%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
1CYTH.MI Yearly Profit, Operating, Gross Margins1CYTH.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CYTH is destroying value.
  • The number of shares outstanding for 1CYTH has been increased compared to 1 year ago.
  • 1CYTH has less shares outstanding than it did 5 years ago.
  • 1CYTH has a better debt/assets ratio than last year.
1CYTH.MI Yearly Shares Outstanding1CYTH.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1CYTH.MI Yearly Total Debt VS Total Assets1CYTH.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • Based on the Altman-Z score of -0.10, we must say that 1CYTH is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of 1CYTH (-0.10) is worse than 83.33% of its industry peers.
  • 1CYTH has a debt to FCF ratio of 14.41. This is a negative value and a sign of low solvency as 1CYTH would need 14.41 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 14.41, 1CYTH is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 14.41
Altman-Z -0.1
ROIC/WACC0.07
WACC6.05%
1CYTH.MI Yearly LT Debt VS Equity VS FCF1CYTH.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 2.21 indicates that 1CYTH has no problem at all paying its short term obligations.
  • 1CYTH's Current ratio of 2.21 is amongst the best of the industry. 1CYTH outperforms 94.44% of its industry peers.
  • 1CYTH has a Quick Ratio of 2.17. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
  • 1CYTH has a better Quick ratio (2.17) than 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.17
1CYTH.MI Yearly Current Assets VS Current Liabilites1CYTH.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • 1CYTH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.73%.
  • The Revenue has decreased by -4.56% in the past year.
  • 1CYTH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.39% yearly.
EPS 1Y (TTM)-22.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-4.56%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-4.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.04% on average over the next years. This is quite good.
  • The Revenue is expected to decrease by -3.84% on average over the next years.
EPS Next Y-205.66%
EPS Next 2Y-50.29%
EPS Next 3Y-2.49%
EPS Next 5Y18.04%
Revenue Next Year-4.41%
Revenue Next 2Y-5.91%
Revenue Next 3Y-5.11%
Revenue Next 5Y-3.84%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1CYTH.MI Yearly Revenue VS Estimates1CYTH.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1CYTH.MI Yearly EPS VS Estimates1CYTH.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 1CYTH. In the last year negative earnings were reported.
  • Also next year 1CYTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1CYTH.MI Price Earnings VS Forward Price Earnings1CYTH.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1CYTH is valued a bit more expensive than 66.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1CYTH indicates a rather cheap valuation: 1CYTH is cheaper than 80.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.22
EV/EBITDA 8.03
1CYTH.MI Per share data1CYTH.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as 1CYTH's earnings are expected to decrease with -2.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-50.29%
EPS Next 3Y-2.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1CYTH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LUMEN TECHNOLOGIES INC

BIT:1CYTH (1/16/2026, 7:00:00 PM)

7.345

-1.79 (-19.61%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)10-30
Earnings (Next)02-03
Inst Owners68.51%
Inst Owner ChangeN/A
Ins Owners7.81%
Ins Owner ChangeN/A
Market Cap7.53B
Revenue(TTM)12.69B
Net Income(TTM)-1.65B
Analysts54.44
Price Target6.27 (-14.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)-68.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.52%
Min EPS beat(2)26.21%
Max EPS beat(2)88.84%
EPS beat(4)4
Avg EPS beat(4)109.8%
Min EPS beat(4)26.21%
Max EPS beat(4)272.03%
EPS beat(8)5
Avg EPS beat(8)-32.55%
EPS beat(12)8
Avg EPS beat(12)-15.53%
EPS beat(16)9
Avg EPS beat(16)-15.24%
Revenue beat(2)0
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.42%
Revenue beat(4)1
Avg Revenue beat(4)-0.28%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-1.07%
Revenue beat(12)1
Avg Revenue beat(12)-1.22%
Revenue beat(16)1
Avg Revenue beat(16)-1.41%
PT rev (1m)41.41%
PT rev (3m)35.25%
EPS NQ rev (1m)-33.18%
EPS NQ rev (3m)-23.85%
EPS NY rev (1m)4.67%
EPS NY rev (3m)5.51%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.7
P/FCF 7.22
P/OCF 1.82
P/B N/A
P/tB N/A
EV/EBITDA 8.03
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)1.02
FCFY13.86%
OCF(TTM)4.04
OCFY54.99%
SpS10.54
BVpS-0.97
TBVpS-4.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.82%
ROE N/A
ROCE 0.56%
ROIC 0.42%
ROICexc 0.46%
ROICexgc 0.54%
OM 1.34%
PM (TTM) N/A
GM 47.07%
FCFM 9.66%
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
ROICexc(3y)3.6%
ROICexc(5y)4.47%
ROICexgc(3y)6.03%
ROICexgc(5y)8.09%
ROCE(3y)4.57%
ROCE(5y)5.8%
ROICexgc growth 3Y-47.53%
ROICexgc growth 5Y-31.85%
ROICexc growth 3Y-41.43%
ROICexc growth 5Y-24.11%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 14.41
Debt/EBITDA 5.85
Cap/Depr 128.42%
Cap/Sales 28.67%
Interest Coverage 0.13
Cash Conversion 161.97%
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.17
Altman-Z -0.1
F-Score5
WACC6.05%
ROIC/WACC0.07
Cap/Depr(3y)102.09%
Cap/Depr(5y)91.52%
Cap/Sales(3y)21.07%
Cap/Sales(5y)19.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y-205.66%
EPS Next 2Y-50.29%
EPS Next 3Y-2.49%
EPS Next 5Y18.04%
Revenue 1Y (TTM)-4.56%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-4.16%
Revenue Next Year-4.41%
Revenue Next 2Y-5.91%
Revenue Next 3Y-5.11%
Revenue Next 5Y-3.84%
EBIT growth 1Y-62.72%
EBIT growth 3Y-51.9%
EBIT growth 5Y-33.9%
EBIT Next Year385.57%
EBIT Next 3Y73.55%
EBIT Next 5Y38.48%
FCF growth 1Y236.98%
FCF growth 3Y-32.61%
FCF growth 5Y-18.43%
OCF growth 1Y119.4%
OCF growth 3Y-12.65%
OCF growth 5Y-8.29%

LUMEN TECHNOLOGIES INC / 1CYTH.MI FAQ

What is the ChartMill fundamental rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1CYTH.MI.


What is the valuation status for 1CYTH stock?

ChartMill assigns a valuation rating of 2 / 10 to LUMEN TECHNOLOGIES INC (1CYTH.MI). This can be considered as Overvalued.


Can you provide the profitability details for LUMEN TECHNOLOGIES INC?

LUMEN TECHNOLOGIES INC (1CYTH.MI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for 1CYTH stock?

The Earnings per Share (EPS) of LUMEN TECHNOLOGIES INC (1CYTH.MI) is expected to decline by -205.66% in the next year.


How sustainable is the dividend of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?

The dividend rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) is 0 / 10 and the dividend payout ratio is 0%.